INCYTE CORP. - Daily - Technical analysis published on 10/15/2019 (GMT)
- 302
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Court terme:
Bullish
De fond:
Bearish
Technical indicators
78%
0%
22%
My opinion
Bearish under 78.51 USD
My targets
75.54 USD (-3.64%)
74.23 USD (-5.31%)
My analysis
The basic trend is bearish on INCYTE CORP. and in the short term, the price is trying to rebound. For the time being, this is only a technical rebound and the basic trend is not threatened. To have the rebound confirmed, it would have at least to go back above the 78.51 USD. Buyers would then use the next resistance located at 81.21 USD as an objective. Crossing it would then enable buyers to target 86.07 USD. If there is a return to below the support located at 75.54 USD, this would be a sign of a reversal in the basic bearish trend. The next bearish objectives would be 74.23 USD and 58.50 USD by extension.
In the very short term, the general bearish opinion of this analysis is in opposition with technical indicators. As long as the invalidation level of this analysis is not breached, the bearish direction is still favored, however the current short term correction should be carefully watched.
FORCE
0
10
0
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The INCYTE CORP. rating is 78.39 USD. The price has increased by +1.20% since the last closing and was between 77.36 USD and 79.06 USD. This implies that the price is at +1.33% from its lowest and at -0.85% from its highest.77.36
79.06
78.39
A bearish opening was detected by the Central Gaps scanner. Sellers are trying to impose a bearish trend in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by INCYTE CORP.:
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of INCYTE CORP. indicates that the overall trend is bearish. The signals given by moving averages are at 64.29% bearish. This bearish trend could slow down given the slightly bullish signals currently being given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
An assessment of technical indicators shows a strong bullish signal.
Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
RSI indicator is back over 50
Type : Bullish
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near horizontal resistance
Type : Bearish
Timeframe : Daily
Resistance of channel is broken
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 58.50 | 74.23 | 75.54 | 78.39 | 78.51 | 81.21 | 86.07 |
| Change (%) | -25.37% | -5.31% | -3.64% | - | +0.15% | +3.60% | +9.80% |
| Change | -19.89 | -4.16 | -2.85 | - | +0.12 | +2.82 | +7.68 |
| Level | Major | Major | Major | - | Intermediate | Minor | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 74.33 | 75.29 | 76.38 | 77.34 | 78.42 | 79.38 | 80.47 |
| Camarilla | 76.90 | 77.09 | 77.27 | 77.46 | 77.65 | 77.84 | 78.02 |
| Woodie | 74.39 | 75.32 | 76.44 | 77.37 | 78.48 | 79.41 | 80.53 |
| Fibonacci | 75.29 | 76.08 | 76.56 | 77.34 | 78.12 | 78.60 | 79.38 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 69.47 | 71.24 | 73.68 | 75.45 | 77.89 | 79.66 | 82.10 |
| Camarilla | 74.96 | 75.35 | 75.73 | 76.12 | 76.51 | 76.89 | 77.28 |
| Woodie | 69.81 | 71.41 | 74.02 | 75.62 | 78.23 | 79.83 | 82.44 |
| Fibonacci | 71.24 | 72.85 | 73.84 | 75.45 | 77.06 | 78.05 | 79.66 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 60.19 | 66.10 | 70.16 | 76.07 | 80.13 | 86.04 | 90.10 |
| Camarilla | 71.49 | 72.40 | 73.32 | 74.23 | 75.14 | 76.06 | 76.97 |
| Woodie | 59.28 | 65.64 | 69.25 | 75.61 | 79.22 | 85.58 | 89.19 |
| Fibonacci | 66.10 | 69.91 | 72.26 | 76.07 | 79.88 | 82.23 | 86.04 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 56.84 | |
| MACD (12,26,9): | -0.5900 | |
| Directional Movement: | 5.78 | |
| AROON (14): | 85.71 | |
| DEMA (21): | 75.19 | |
| Parabolic SAR (0,02-0,02-0,2): | 72.35 | |
| Elder Ray (13): | 2.17 | |
| Super Trend (3,10): | 80.65 | |
| Zig ZAG (10): | 78.37 | |
| VORTEX (21): | 1.0200 | |
| Stochastique (14,3,5): | 80.25 | |
| TEMA (21): | 75.70 | |
| Williams %R (14): | -11.47 | |
| Chande Momentum Oscillator (20): | 5.43 | |
| Repulse (5,40,3): | 2.0300 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -0.2400 | |
| Courbe Coppock: | 1.17 |
| MA7: | 75.95 | |
| MA20: | 75.85 | |
| MA50: | 78.91 | |
| MA100: | 80.41 | |
| MAexp7: | 76.43 | |
| MAexp20: | 76.30 | |
| MAexp50: | 78.02 | |
| MAexp100: | 79.06 | |
| Price / MA7: | +3.21% | |
| Price / MA20: | +3.35% | |
| Price / MA50: | -0.66% | |
| Price / MA100: | -2.51% | |
| Price / MAexp7: | +2.56% | |
| Price / MAexp20: | +2.74% | |
| Price / MAexp50: | +0.47% | |
| Price / MAexp100: | -0.85% |
News
The last news published on INCYTE CORP. at the time of the generation of this analysis was as follows:
- Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo
- Incyte to Report Third Quarter Financial Results
- Incyte Announces Positive Updated Results from Phase 2 Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma
- Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo
- Incyte to Host Investor Conference Call from ESMO 2019
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis INCYTE CORP. - Daily